What is the treatment for a suspected acetaminophen (Tylenol) overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment of Acetaminophen (Tylenol) Overdose

Administer N-acetylcysteine (NAC) immediately to any patient with suspected acetaminophen overdose—do not wait for laboratory confirmation if the ingestion occurred within 24 hours, as treatment within 8 hours prevents severe hepatotoxicity in 97% of cases. 1

Immediate Actions (Do Not Delay)

  • Start NAC immediately if the patient presents within 24 hours of ingestion, regardless of acetaminophen level results 2
  • Administer activated charcoal 1 g/kg orally if the patient presents within 4 hours of ingestion, given just prior to starting NAC 1
  • Draw blood for: acetaminophen level (if ≥4 hours post-ingestion), AST, ALT, INR, creatinine, BUN, electrolytes, and glucose 3, 2
  • If acetaminophen level is drawn before 4 hours post-ingestion, it is unreliable and must be repeated at 4 hours 1

NAC Dosing Regimens

Intravenous (20-hour protocol): 1

  • Loading dose: 150 mg/kg in 5% dextrose over 15 minutes
  • Second dose: 50 mg/kg over 4 hours
  • Third dose: 100 mg/kg over 16 hours

Oral (72-hour protocol): 1, 2

  • Loading dose: 140 mg/kg diluted to 5% solution
  • Maintenance: 70 mg/kg every 4 hours for 17 additional doses
  • The 72-hour oral regimen may be superior when treatment is delayed 1

Risk Stratification Using the Rumack-Matthew Nomogram

Use the nomogram ONLY for: 4, 1

  • Single acute ingestions with known time of ingestion
  • Acetaminophen levels drawn 4-24 hours post-ingestion

Administer NAC if: 4, 1

  • Acetaminophen level plots at or above the "possible toxicity" line (≥200 mcg/mL at 4 hours or ≥50 mcg/mL at 12 hours)
  • Level plots above the treatment line at any point between 4-24 hours

Do NOT use the nomogram for: 1

  • Presentations >24 hours post-ingestion
  • Extended-release formulations
  • Repeated supratherapeutic ingestions
  • Unknown time of ingestion

Special Clinical Scenarios Requiring NAC (Regardless of Nomogram)

Treat immediately with NAC if ANY of the following: 1

  • Hepatotoxicity already present: AST or ALT >50 IU/L with any detectable acetaminophen level 1
  • Severe hepatotoxicity: AST or ALT >1,000 IU/L (even without clear overdose history) 1
  • Acute liver failure: Elevated transaminases "in the thousands" with elevated bilirubin and INR 1
  • Unknown time of ingestion with detectable acetaminophen level 1
  • Extended-release acetaminophen: Obtain serial levels at 4 hours and again 4-6 hours later, as absorption continues beyond 8-14 hours and levels may rise late 5, 1
  • Repeated supratherapeutic ingestion: ≥10 g or 200 mg/kg in 24 hours, OR ≥6 g or 150 mg/kg per day for ≥48 hours 1
  • High-risk patients (chronic alcohol use, liver disease): Treat even with levels in "non-toxic" range, as hepatotoxicity occurs with doses as low as 4 g/day 1

Critical Timing and Efficacy Data

Treatment efficacy decreases dramatically with delay: 1

  • 0-8 hours: 2.9% develop severe hepatotoxicity
  • 8-10 hours: 6.1% develop severe hepatotoxicity
  • 10-24 hours: 26.4% develop severe hepatotoxicity
  • >24 hours: Still beneficial (reduces mortality from 80% to 52% in fulminant hepatic failure) but significantly less effective 1

When to Continue NAC Beyond Standard Protocol

Extend NAC treatment if: 1

  • Acetaminophen level remains detectable
  • AST or ALT is elevated or rising
  • Any coagulopathy (elevated INR)
  • Delayed presentation (>24 hours)
  • Extended-release formulation
  • Repeated supratherapeutic ingestion
  • Unknown time of ingestion

Continue NAC until: 1

  • Acetaminophen level is undetectable AND
  • AST/ALT are normal or declining AND
  • INR is normal

Management of Established Hepatotoxicity

If severe hepatotoxicity develops (AST/ALT >1,000 IU/L): 1

  • Continue or restart NAC immediately (reduces mortality from 80% to 52%) 1
  • Admit to ICU for monitoring of encephalopathy, coagulopathy, renal failure, and metabolic derangements 1
  • Contact liver transplant center immediately 1
  • Monitor AST, ALT, and INR every 4 hours until aminotransferases peak and decline 3

Common Pitfalls to Avoid

  • Do not wait for acetaminophen levels if ingestion occurred within 24 hours—start NAC immediately 2
  • Do not rely on a single 4-hour level for extended-release formulations—obtain a second level 4-6 hours later, as three patients in one series had initial levels below the treatment line that later rose above it 5
  • Do not stop NAC prematurely—verify acetaminophen is undetectable AND transaminases are normal/declining before discontinuing 1
  • Low or absent acetaminophen levels do not rule out poisoning if ingestion was remote or occurred over several days 1
  • Very high aminotransferases (>3,500 IU/L) are highly correlated with acetaminophen poisoning even without clear overdose history 3
  • If patient vomits oral NAC within 1 hour, repeat that dose 2
  • Chronic alcoholics require treatment even with "non-toxic" levels, as severe hepatotoxicity occurs with doses as low as 4-5 g/day 1

Monitoring During Treatment

  • Repeat AST, ALT, INR, creatinine, BUN, glucose, and electrolytes daily if acetaminophen level is in the potentially toxic range 2
  • Monitor AST, ALT, and INR every 4 hours if hepatotoxicity is developing 3
  • Add phosphate monitoring if acute liver failure develops 3

References

Guideline

Acetaminophen Overdose Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Laboratory Testing in Acetaminophen Overdose

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Tylenol Extended Relief overdose.

Annals of emergency medicine, 1997

Related Questions

What are the appropriate antipyretics (fever-reducing medications) for patients with impaired renal function?
What is the treatment for an Acetylsalicylic Acid (ASA) overdose?
What are the next steps for a 3-year-old patient who was alone for 15 minutes and may have ingested an undisclosed amount of Tylenol (acetaminophen)?
For a 9.5 kg infant, what is the appropriate acetaminophen (Tylenol) dose in milligrams per administration?
What are the implications of taking 1500 mg of Tylenol (acetaminophen) in a single dose instead of the intended 1000 mg?
What is the proper dosing and administration of Glycoair (glycopyrrolate/formoterol fumarate) for a patient with severe Chronic Obstructive Pulmonary Disease (COPD) and a history of exacerbations?
What is the optimal timing for taking modafinil (provigil) in patients with narcolepsy, obstructive sleep apnea (OSA), or shift work sleep disorder?
What does it mean for an adult male with no significant past medical history to have a total testosterone level of 357 ng/dL and a free testosterone level of 3.8?
Can an Epsom salt soak help alleviate gout pain in a patient, especially one with potential underlying medical conditions such as kidney disease or heart problems?
Can a patient with end-stage renal disease and potential comorbid conditions such as diabetes or hypertension leave tissue plasminogen activator (TPA) (alteplase) in their dialysis catheter for 24 hours?
Does atomoxetine (Strattera) need to be held on the day of surgery or anesthesia in a patient with Attention Deficit Hyperactivity Disorder (ADHD)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.